STOK EBITDA Growth
Stoke Therapeutics Inc · EBITDA Growth
STOK EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-471.83%period ending
STOK TTM EBITDA YoY % (-180.31% → -471.83%)
Year-over-year change
High-resolution chart · PNG
STOK ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -471.8265% | |
| -408.2773% | |
| 94.7445% | |
| 141.6817% | |
| 155.0916% | |
| 150.5604% | |
| 15.0895% | |
| -2.2191% | |
| 1.521% | |
| -9.2987% | |
| -2.722% | |
| -2.284% | |
| -7.8189% | |
| -4.738% | |
| -17.2698% | |
| -31.5822% | |
| -44.1113% | |
| -62.0068% | |
| -62.7138% | |
| -53.8924% | |
| -47.0484% | |
| -41.1528% | |
| -48.0569% | |
| -69.4281% | |
| -101.6635% | |
| -139.3939% | |
| -180.3135% |